AI assistant
Sending…
XBiotech Inc. — Director's Dealing 2019
Jun 6, 2019
34229_dirs_2019-06-06_d4921089-e22e-4b3e-9daa-07ecd760f85c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2019-06-04
Reporting Person: RENNES FONDATION (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-06-04 | Common Stock | P | 1200000 | $8.25 | Acquired | 5110282 | Direct |
Footnotes
F1: Represents a purchase from the underwriter in the Issuer's public offering.
More from XBiotech Inc.
Interim / Quarterly Report
2026
May 14
Annual Report
2026
Apr 29
Major Shareholding Notification
2026
Jan 23
Major Shareholding Notification
2026
Jan 23
Regulatory Filings
2025
Dec 9
Interim / Quarterly Report
2025
Nov 12
Director's Dealing
2025
Nov 12
Director's Dealing
2025
Nov 12
Director's Dealing
2025
Nov 12
Director's Dealing
2025
Nov 12